Drug Developement/Delivery
- Nanovaccines: Current Advances and Challenges
- COVID-19 mRNA Vaccine Excipients - PEG Products Supply
- HER2 Targeted Therapies In Breast Cancer
- c-MET: A Novel Target for Anticancer Therapies
- Advantages and Disadvantages of PEGylated Liposomes in Drug Delivery System
- Anti-obesity Medications (AOMs): History And Progress
- Clinical Development of ADC Drugs Targeting TROP-2
- PROTACs VS. Traditional Small Molecule Inhibitors
- Summary of PROTAC Degraders in Clinical Trials
- Trophoblast Glycoprotein (TPGB/5T4): A New Target For ADC Drugs
